Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
8296.HK Stock Summary
In the News
8296.HK Financial details
Company Rating
Buy
Market Cap
121.03M
Income
-17.32M
Revenue
76.28M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
171
Optionable
No
Shortable
Yes
Earnings
11 Nov 2022
P/E
-6.52
Forward P/E
-
PEG
-0.14
P/S
1.48
P/B
1.03
P/C
-
P/FCF
-
Quick Ratio
1.33
Current Ratio
1.61
Debt / Equity
-
LT Debt / Equity
0.23
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
232.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-12.55%
Revenue last 5Y
3.72%
Revenue Q/Q
20.84%
EPS Q/Q
-124.21%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-15%
ROC
-0.11%
Gross Margin
51%
Oper. Margin
-22%
Profit Margin
-23%
Payout
-
Shs Outstand
742.5M
Shs Float
522.02M
-
-
-
-
Target Price
-
52W Range
0.099-0.199
52W High
-
52W Low
-
RSI
46
Rel Volume
2.37
Avg Volume
421.17K
Volume
1000K
Perf Week
-7.32%
Perf Month
-6.17%
Perf Quarter
-3.8%
Perf Half Y
-5%
-
-
-
-
Beta
0.300967
-
-
Volatility
0%, 0%
Prev Close
-3.8%
Price
0.152
Change
-3.8%
8296.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.08 | 0.08 | 0.09 | 0.09 | 0.1 | |
Net income per share | -0.03 | -0.01 | -0.01 | 0 | -0.01 | |
Operating cash flow per share | 0 | 0.01 | 0.01 | 0.02 | 0 | |
Free cash flow per share | 0 | 0 | 0.01 | 0.02 | -0.01 | |
Cash per share | 0.18 | 0.18 | 0.21 | 0.21 | 0.21 | |
Book value per share | 0.15 | 0.14 | 0.17 | 0.16 | 0.15 | |
Tangible book value per share | 0.14 | 0.13 | 0.16 | 0.15 | 0.14 | |
Share holders equity per share | 0.15 | 0.14 | 0.17 | 0.16 | 0.15 | |
Interest debt per share | 0.01 | 0.01 | 0.06 | 0.06 | 0.05 | |
Market cap | 187.65M | 155.17M | 89.4M | 100.46M | 107.87M | |
Enterprise value | 99.59M | 61.01M | 13.44M | 15.62M | 23.8M | |
P/E ratio | -9.71 | -18.58 | -23.5 | -33.78 | -10.93 | |
Price to sales ratio | 3.09 | 2.48 | 1.34 | 1.47 | 1.48 | |
POCF ratio | 155.08 | 31.1 | 15.09 | 5.62 | -265.03 | |
PFCF ratio | -1.63K | 45.04 | 17.3 | 7.09 | -25.03 | |
P/B Ratio | 1.64 | 1.47 | 0.71 | 0.84 | 0.94 | |
PTB ratio | 1.64 | 1.47 | 0.71 | 0.84 | 0.94 | |
EV to sales | 1.64 | 0.97 | 0.2 | 0.23 | 0.33 | |
Enterprise value over EBITDA | -8.38 | -14.87 | 1.92 | 1.17 | 6.75 | |
EV to operating cash flow | 82.31 | 12.23 | 2.27 | 0.87 | -58.48 | |
EV to free cash flow | -866.01 | 17.71 | 2.6 | 1.1 | -5.52 | |
Earnings yield | -0.1 | -0.05 | -0.04 | -0.03 | -0.09 | |
Free cash flow yield | 0 | 0.02 | 0.06 | 0.14 | -0.04 | |
Debt to equity | 1.05 | 1.27 | 1.39 | 1.39 | 1.38 | |
Debt to assets | 0.52 | 0.57 | 0.6 | 0.6 | 0.6 | |
Net debt to EBITDA | 7.41 | 22.95 | -10.88 | -6.33 | -23.83 | |
Current ratio | 1.66 | 1.54 | 1.58 | 1.59 | 1.48 | |
Interest coverage | -102.95 | -3.52 | -1.23 | 0.6 | -5.77 | |
Income quality | -0.06 | -0.6 | -1.56 | -6.02 | 0.04 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.48 | 0.4 | 0.42 | 0.36 | 0.49 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.01 | 0 | 0 | 0.01 | |
Capex to operating cash flow | -1.1 | -0.31 | -0.13 | -0.21 | 9.59 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | -0.05 | -0.05 | |
Capex to depreciation | -0.23 | -0.54 | -0.11 | -0.36 | -0.47 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.3 | 0.19 | 0.14 | 0.12 | 0.21 | |
ROIC | -0.63 | -0.04 | -0.09 | -0.07 | -0.57 | |
Return on tangible assets | -0.09 | -0.04 | -0.01 | -0.01 | -0.04 | |
Graham Net | 0.02 | 0 | -0.02 | -0.01 | 0 | |
Working capital | 73.31M | 67.97M | 79.58M | 76.49M | 62.8M | |
Tangible asset value | 105.92M | 100.07M | 117.65M | 111.72M | 103.56M | |
Net current asset value | 64.09M | 59.74M | 41.08M | 41.33M | 34.71M | |
Invested capital | 0.09 | 0.09 | 0.34 | 0.33 | 0.29 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 4.98M | 2.13M | 3.01M | 2.62M | 2.22M | |
Average inventory | 1.32M | 1.1M | 1.03M | 1.26M | 1.59M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 15.36 | 31.42 | 31.94 | 20.66 | 23.24 | |
Days of inventory on hand | 13.48 | 11.39 | 10.2 | 14.41 | 17 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 23.77 | 11.62 | 11.43 | 17.67 | 15.71 | |
Inventory turnover | 27.08 | 32.05 | 35.78 | 25.34 | 21.47 | |
ROE | -0.17 | -0.08 | -0.03 | -0.02 | -0.09 | |
Capex per share | 0 | 0 | 0 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | |
Net income per share | 0 | -0.02 | 0 | -0.01 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0.21 | 0 | 0.23 | 0 | |
Book value per share | 0 | 0.15 | 0 | 0.15 | 0 | |
Tangible book value per share | 0 | 0.14 | 0 | 0.16 | 0 | |
Share holders equity per share | 0 | 0.15 | 0 | 0.15 | 0 | |
Interest debt per share | 0 | 0.05 | 0 | 0.04 | 0 | |
Market cap | 107.46M | 107.87M | 84.31M | 89.29M | 96.23M | |
Enterprise value | 0 | 23.8M | 0 | -5.31M | 0 | |
P/E ratio | 60.78 | -2.13 | 29.19 | -3.15 | 14.15 | |
Price to sales ratio | 6.52 | 5.64 | 4.1 | 5.39 | 4.81 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0.94 | 0 | 0.81 | 0 | |
PTB ratio | 0 | 0.94 | 0 | 0.81 | 0 | |
EV to sales | 0 | 1.25 | 0 | -0.32 | 0 | |
Enterprise value over EBITDA | 0 | -1.82 | 0 | 2.26 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | -0.12 | 0.01 | -0.08 | 0.02 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 1.38 | 0 | 1.42 | 0 | |
Debt to assets | 0 | 0.6 | 0 | 0.56 | 0 | |
Net debt to EBITDA | 0 | 6.44 | 0 | 40.2 | 0 | |
Current ratio | 0 | 1.48 | 0 | 1.61 | 0 | |
Interest coverage | 2.04 | -42.4 | 5.19 | -6.32 | 8.81 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.39 | 0.8 | 0.32 | 0.76 | 0.28 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0.24 | 0 | 0.18 | 0 | |
ROIC | 0 | -0.73 | 0 | -0.27 | 0 | |
Return on tangible assets | 0 | -0.05 | 0 | -0.03 | 0 | |
Graham Net | 0 | 0 | 0 | 0.02 | 0 | |
Working capital | 0 | 62.8M | 0 | 78.99M | 0 | |
Tangible asset value | 0 | 103.56M | 0 | 119.76M | 0 | |
Net current asset value | 0 | 34.71M | 0 | 53.92M | 0 | |
Invested capital | 0 | 0.29 | 0 | 0.28 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 17.13 | 0 | 20.74 | 0 | |
Days of inventory on hand | 0 | 12.53 | 0 | 18.14 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 5.25 | 0 | 4.34 | 0 | |
Inventory turnover | 0 | 7.18 | 0 | 4.96 | 0 | |
ROE | 0 | -0.11 | 0 | -0.06 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
8296.HK Frequently Asked Questions
What is Sino-Life Group Limited stock symbol ?
Sino-Life Group Limited is a HK stock and trading under the symbol 8296.HK
What is Sino-Life Group Limited stock quote today ?
Sino-Life Group Limited stock price is $0.152 today.
Is Sino-Life Group Limited stock public?
Yes, Sino-Life Group Limited is a publicly traded company.